A Systematic Literature Review of Alopecia Areata in Children and Adolescents: Psychosocial Impact
Main Article Content
Keywords
systematic literature review , alopecia areata , children and adolescents, psychosocial impact
References
1. Zhou J, et al. J Cosmet Dermatol. 2025;24(3):e70076
2. Sejdiu Z, et al. Clin Exp Dermatol. 2024;49:1118–1124
3. NAAF FDA-Approved JAK Inhibitors 2025. Available at https://www.naaf.org/navigation-toolkit/fda-approved-jak-inhibitors/ (accessed September 2025)
4. Altunisik N, et al. J Cosmet Dermatol. 2022;21(2): 770–775
5. Andreoli E, et al. Dermatol Psychosom. 2002;3(1): 26–29
6. Aşkın Ö, et al. Int J Adolesc Med Health. 2020; 34(5): 315–318
7. Benton S, et al. Pediatr Dermatol. 2021;38(5): 1415–1416
8. Benton S, et al. Pediatr Dermatol. 2023;40(2): 312–314
9. Bilgic Ö, et al. J Eur Acad Dermatol Venereol. 2014;28(11): 1463–1468
10. Chong JH, et al. J Eur Acad Dermatol Venereol. 2017;31(11): e476–e477
11. Christensen T, et al. Skin Appendage Disord. 2017;3(3): 115–118
12. Cohen RD. Dermatol Psychosom. 2002;3(3): 150–152
13. Constantopoulos A, et al. J Eur Acad Dermatol Venereol. 1996; 7(2): 190–192
14. De Waard-Van der Spek FB, et al. J Eur Acad Dermatol Venereol. 1994; 3(1): 16–21
15. Demir D, et al. 32nd EADV Congress; 11 Oct–14 Oct 2023; abstract 2781
16. Lewis-Jones MS, et al. British Journal of Dermatology. 1995;132(6): 942–949
17. Liakopoulou M, et al. J Am Acad Child Adolesc Psychiatry. 1997;36(5): 678–684
18. Macey J, et al. British Journal of Dermatology. 2022;186(5): 849–860
19. Martínez-Gayosso A, et al. Pediatr Dermatol. 2024;41(5): 965
20. Reeve E, et al. J Am Acad Child Adolesc Psychiatry. 1996;35(11): 1518–1522
21. Saraswat N, et al. Indian J Dermatol. 2020;65(3): 183–186
22. Savaş Erdoğan S, et al. J Cosmet Dermatol. 2021; 20(7): 2232–2239
23. Selçukoğlu Kilimci Ö, et al. Arch Dermatol Res. 2024;316: 260
24. Toback C, et al. Child Psych Hum Dev. 1979; 10(2): 114–117
25. Ungar B, et al. J Am Acad Dermatol. 2024;91(3): AB275
26. Yucesoy SN, et al. Int J Dermatol. 2024;63: 1414–1420
27. Liu LY, et al. J Am Acad Dermatol. 2018;79(3): 556–558.e1
2. Sejdiu Z, et al. Clin Exp Dermatol. 2024;49:1118–1124
3. NAAF FDA-Approved JAK Inhibitors 2025. Available at https://www.naaf.org/navigation-toolkit/fda-approved-jak-inhibitors/ (accessed September 2025)
4. Altunisik N, et al. J Cosmet Dermatol. 2022;21(2): 770–775
5. Andreoli E, et al. Dermatol Psychosom. 2002;3(1): 26–29
6. Aşkın Ö, et al. Int J Adolesc Med Health. 2020; 34(5): 315–318
7. Benton S, et al. Pediatr Dermatol. 2021;38(5): 1415–1416
8. Benton S, et al. Pediatr Dermatol. 2023;40(2): 312–314
9. Bilgic Ö, et al. J Eur Acad Dermatol Venereol. 2014;28(11): 1463–1468
10. Chong JH, et al. J Eur Acad Dermatol Venereol. 2017;31(11): e476–e477
11. Christensen T, et al. Skin Appendage Disord. 2017;3(3): 115–118
12. Cohen RD. Dermatol Psychosom. 2002;3(3): 150–152
13. Constantopoulos A, et al. J Eur Acad Dermatol Venereol. 1996; 7(2): 190–192
14. De Waard-Van der Spek FB, et al. J Eur Acad Dermatol Venereol. 1994; 3(1): 16–21
15. Demir D, et al. 32nd EADV Congress; 11 Oct–14 Oct 2023; abstract 2781
16. Lewis-Jones MS, et al. British Journal of Dermatology. 1995;132(6): 942–949
17. Liakopoulou M, et al. J Am Acad Child Adolesc Psychiatry. 1997;36(5): 678–684
18. Macey J, et al. British Journal of Dermatology. 2022;186(5): 849–860
19. Martínez-Gayosso A, et al. Pediatr Dermatol. 2024;41(5): 965
20. Reeve E, et al. J Am Acad Child Adolesc Psychiatry. 1996;35(11): 1518–1522
21. Saraswat N, et al. Indian J Dermatol. 2020;65(3): 183–186
22. Savaş Erdoğan S, et al. J Cosmet Dermatol. 2021; 20(7): 2232–2239
23. Selçukoğlu Kilimci Ö, et al. Arch Dermatol Res. 2024;316: 260
24. Toback C, et al. Child Psych Hum Dev. 1979; 10(2): 114–117
25. Ungar B, et al. J Am Acad Dermatol. 2024;91(3): AB275
26. Yucesoy SN, et al. Int J Dermatol. 2024;63: 1414–1420
27. Liu LY, et al. J Am Acad Dermatol. 2018;79(3): 556–558.e1
